Dr Agarwals Health Care Ltd

Dr Agarwal's Hea Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Dr Agarwals Health Care Ltd

₹ 506 -0.05%
25 Nov - close price
dragarwals.co.in BSE: 544350 NSE: AGARWALEYE
About

Incorporated in 2010,[1]Dr. Agarwal’s Health Care offers a wide array of eye care services, which include cataract and refractive surgeries, consultations, diagnoses, and non-surgical treatments. Additionally, they provide optical products, contact lenses, accessories, and pharmaceutical items related to eye care. [2]

Key Points

Largest Eyecare Service Provider[1]
Dr. Agarwal is India's largest eye care service chain with a 25% market share. It is the largest company by revenue in FY23, with more than two times the revenue from operations of the second-largest eye care service chain in the country.

Website BSE NSE
  • Market Cap ₹ 16,065 Cr.
  • Current Price ₹ 506
  • High / Low ₹ 568 / 327
  • Stock P/E 306
  • Book Value ₹ 61.8
  • Dividend Yield 0.00 %
  • ROCE 5.94 %
  • ROE 1.31 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company has delivered good profit growth of 20.9% CAGR over last 5 years

Cons

  • Stock is trading at 8.19 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • Company has a low return on equity of 3.29% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of BSE Healthcare Nifty 500 BSE SmallCap BSE IPO BSE Allcap

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
212.89 224.78 239.60 255.34 267.93 281.02 301.72 308.98
157.73 157.31 190.40 197.58 203.22 207.59 234.92 240.12
Operating Profit 55.16 67.47 49.20 57.76 64.71 73.43 66.80 68.86
OPM % 25.91% 30.02% 20.53% 22.62% 24.15% 26.13% 22.14% 22.29%
13.41 13.32 2.18 4.66 9.77 23.72 12.32 6.09
Interest 21.71 22.32 22.62 23.40 23.38 20.90 19.32 17.29
Depreciation 31.58 34.88 36.88 38.45 39.00 42.20 44.21 48.10
Profit before tax 15.28 23.59 -8.12 0.57 12.10 34.05 15.59 9.56
Tax % 37.11% 29.29% 4.93% 745.61% 37.02% 22.14% 35.15% 51.05%
9.61 16.68 -8.52 -3.68 7.62 26.51 10.11 4.68
EPS in Rs 0.25 0.84 0.32 0.15
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
202 248 232 362 598 835 1,044 1,160
186 202 199 275 436 611 795 886
Operating Profit 16 46 33 86 162 224 249 274
OPM % 8% 19% 14% 24% 27% 27% 24% 24%
5 9 4 10 -12 38 40 52
Interest 20 42 34 38 64 88 94 81
Depreciation 21 49 55 59 92 129 156 174
Profit before tax -20 -36 -52 -1 -6 45 39 71
Tax % 0% 0% 4% 55% -641% 47% 43%
-20 -36 -54 -1 32 24 22 49
EPS in Rs 0.69 1.56
Dividend Payout % 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 33%
3 Years: 42%
TTM: 24%
Compounded Profit Growth
10 Years: %
5 Years: 21%
3 Years: 152%
TTM: 140%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: 1%
3 Years: 3%
Last Year: 1%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 7 7 7 7 8 9 32 32
Reserves 290 248 194 192 554 1,218 1,902 1,924
135 142 161 252 590 661 568 589
60 200 281 242 236 298 335 299
Total Liabilities 492 596 643 692 1,388 2,187 2,837 2,844
99 322 387 367 907 1,302 1,591 1,769
CWIP 1 3 11 2 35 9 18 5
Investments 238 146 121 147 187 629 729 670
154 124 124 176 258 248 498 400
Total Assets 492 596 643 692 1,388 2,187 2,837 2,844

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
40 46 78 153 222 208
-37 -26 -98 -436 -818 -577
-60 -21 40 316 570 374
Net Cash Flow -56 -1 20 33 -26 5

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 46 46 39 31 24 22 25
Inventory Days 138 159 147 149 119 135 174
Days Payable 330 427 608 456 354 383 375
Cash Conversion Cycle -147 -222 -422 -276 -210 -226 -176
Working Capital Days 5 -37 -43 -54 -88 -79 -55
ROCE % 1% -5% 9% 10% 8% 6%

Shareholding Pattern

Numbers in percentages

4 Recently
Mar 2025Jun 2025Sep 2025
32.45% 32.43% 32.43%
60.62% 59.26% 58.13%
5.21% 6.44% 7.92%
1.74% 1.87% 1.52%
No. of Shareholders 68,69663,02148,168

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls